Lung cancer kills more people worldwide than any other malignancy, and the reason is painfully simple: it is usually caught ...

A new commentary argues that lung nodule localisation is entering a precision era, as stabilised fluorescent matrices aim to solve the diffusion problem that undermines surgical margins in robotic ...

Cizzle Bio is developing a blood test designed to add biomarker information to existing lung cancer screening.

The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive ...

A simple breath test could help doctors determine whether suspicious lung nodules are cancerous without immediately turning ...

A risk score built from 31 small RNA molecules found in blood was linked to lung cancer up to 10 years before diagnosis in a ...

Baptist Health Paducah will set aside low dose lung cancer screening appointments Friday, Nov. 13, in recognition of Lung ...

Cizzle Biotechnology has moved its CIZ1B biomarker blood test into commercialisation after securing US clinical accreditation ...

LUCAS, a first of its kind, state-of-the-art mobile lung cancer screening unit, will visit Morgan, Tucker, and Preston ...

There is no blood test, including a complete blood count (CBC), that can diagnose lung cancer on its own. Low-dose CT (LDCT) scans are the gold standard for early lung cancer detection and can reduce ...

Lung cancer screening eligibility increased markedly from 2018–2023 under USPSTF criteria, reflecting aging and substantial ...

Lung cancer affects non-smokers, with 25% of patients having never smoked, highlighting the need for awareness of persistent symptoms and environmental risk factors. Genetic testing is essential for ...